75A50122C00065 — AMGEN USA INC — Department of Health and Human Services ($839,875,190)

TREATMENT FOR USE IN A MASS CASUALTY EVENT WHERE THROMBOCYTOPENIA OR PLATELET LOSS IS A MAJOR CONCERN. Recipient: AMGEN USA INC Obligated amount: $839,875,190 Awarding agency: Department of Health and Human Services (Office of Assistant Secretary for Preparedness and Response) Procurement instrument identifier (PIID): 75A50122C00065 Start date: 2022-09-30 End date: 2032-09-29

Related documents

• 75FCMC20F0003 — KPMG LLP — Department of Health and Human Services ($50,926,507)#601653
• 75F40125F19011 — DELOITTE CONSULTING LLP — Department of Health and Human Services ($30,607,197)#602123
• 75F40120F19002 — DELOITTE & TOUCHE LLP — Department of Health and Human Services ($38,887,161)#601877
• 19AQMM22F7129 — CGI FEDERAL INC. — Department of State ($63,867,220)#601534
• N0002420C5503 — LOCKHEED MARTIN CORPORATION — Department of Defense ($783,182,343)#605499